Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigehisa Kitano

Showing results (51-60 of 150) with videos related to

Pageof 15
Sort By:
Breast Cancer Research : BCR|October 30, 2021
Plasma cell infiltration and treatment effect in breast cancer patients treated with neoadjuvant chemotherapyAsumi Sakaguchi, Yoshiya Horimoto, Hiroko Onagi, et al.
Cancer Science|December 5, 2019
First-in-human phase I study of E7090, a novel selective fibroblast growth factor receptor inhibitor, in patients with advanced solid tumorsTakafumi Koyama, Toshio Shimizu, Satoru Iwasa, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2026
Immunological profile of the tumor immune microenvironment of upper tract urothelial carcinoma predicts recurrence patternsKenta Takahashi, Daiki Ikarashi, Shigehisa Kitano, et al.
Scientific Reports|January 16, 2024
Pathological complete response to neoadjuvant chemotherapy may improve antitumor immune response via reduction of regulatory T cells in muscle-invasive bladder cancerDaiki Ikarashi, Shigehisa Kitano, Takashi Tsuyukubo, et al.
Lung Cancer (Amsterdam, Netherlands)|July 6, 2017
DNA mismatch repair deficiency in surgically resected lung adenocarcinoma: Microsatellite instability analysis using the Promega panelKazuya Takamochi, Fumiyuki Takahashi, Yoshiyuki Suehara, et al.
Annals of Surgical Oncology|July 2, 2016
High Absolute Monocyte Count Predicts Poor Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Treated with Docetaxel ChemotherapyKeisuke Shigeta, Takeo Kosaka, Shigehisa Kitano, et al.
Annals of Surgical Oncology|May 9, 2025
Correction to: High Absolute Monocyte Count Predicts Poor Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Treated with Docetaxel ChemotherapyKeisuke Shigeta, Takeo Kosaka, Shigehisa Kitano, et al.
Cancer Immunology Research|January 8, 2014
Enhancement of tumor-reactive cytotoxic CD4+ T cell responses after ipilimumab treatment in four advanced melanoma patientsShigehisa Kitano, Takemasa Tsuji, Caillian Liu, et al.
Oncology Letters|January 29, 2021
Immunological status of peripheral blood is associated with prognosis in patients with bone and soft-tissue sarcomaYoungji Kim, Eisuke Kobayashi, Yoshiyuki Suehara, et al.
International Journal of Clinical Oncology|November 29, 2023
Clinical practice guidelines for molecular tumor markers, 2nd edition review part 1Yoshinori Kikuchi, Hideaki Shimada, Yutaka Hatanaka, et al.
Pageof 15

Showing results (51-60 of 150) with videos related to

Sort By:
Pageof 15
Breast Cancer Research : BCR|October 30, 2021
Plasma cell infiltration and treatment effect in breast cancer patients treated with neoadjuvant chemotherapyAsumi Sakaguchi, Yoshiya Horimoto, Hiroko Onagi, et al.
Cancer Science|December 5, 2019
First-in-human phase I study of E7090, a novel selective fibroblast growth factor receptor inhibitor, in patients with advanced solid tumorsTakafumi Koyama, Toshio Shimizu, Satoru Iwasa, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2026
Immunological profile of the tumor immune microenvironment of upper tract urothelial carcinoma predicts recurrence patternsKenta Takahashi, Daiki Ikarashi, Shigehisa Kitano, et al.
Scientific Reports|January 16, 2024
Pathological complete response to neoadjuvant chemotherapy may improve antitumor immune response via reduction of regulatory T cells in muscle-invasive bladder cancerDaiki Ikarashi, Shigehisa Kitano, Takashi Tsuyukubo, et al.
Lung Cancer (Amsterdam, Netherlands)|July 6, 2017
DNA mismatch repair deficiency in surgically resected lung adenocarcinoma: Microsatellite instability analysis using the Promega panelKazuya Takamochi, Fumiyuki Takahashi, Yoshiyuki Suehara, et al.
Annals of Surgical Oncology|July 2, 2016
High Absolute Monocyte Count Predicts Poor Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Treated with Docetaxel ChemotherapyKeisuke Shigeta, Takeo Kosaka, Shigehisa Kitano, et al.
Annals of Surgical Oncology|May 9, 2025
Correction to: High Absolute Monocyte Count Predicts Poor Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Treated with Docetaxel ChemotherapyKeisuke Shigeta, Takeo Kosaka, Shigehisa Kitano, et al.
Cancer Immunology Research|January 8, 2014
Enhancement of tumor-reactive cytotoxic CD4+ T cell responses after ipilimumab treatment in four advanced melanoma patientsShigehisa Kitano, Takemasa Tsuji, Caillian Liu, et al.
Oncology Letters|January 29, 2021
Immunological status of peripheral blood is associated with prognosis in patients with bone and soft-tissue sarcomaYoungji Kim, Eisuke Kobayashi, Yoshiyuki Suehara, et al.
International Journal of Clinical Oncology|November 29, 2023
Clinical practice guidelines for molecular tumor markers, 2nd edition review part 1Yoshinori Kikuchi, Hideaki Shimada, Yutaka Hatanaka, et al.
Pageof 15